April 2025
Published: 08 Apr 2025
Author: Precedence Research
Metropolis Healthcare Ltd has acquired Ahujas' Pathology and Imaging Centre (DAPIC) for Rs 35.01 crore in an all-cash transaction. This strategic step is expected to accelerate the company's pace on the Indian northern steer towards high-growth Uttarakhand and Uttar Pradesh states as these are regions with great potential for diagnostic services. Under the agreement of business transfer, 100 percent ownership of the DAPIC will be acquired by Metropolis Histoxpert Digital Services Pvt Ltd, a company subsidiary. DAPIC, which was established in 1990 by Alok Ahuja and Alka Ahuja, boasts of two NABL- and NABH-accredited laboratories, 11 patient service centers, and nine hospital-based centers.
Metropolis Healthcare has made this acquisition as it has further entered the takeover phase with Pathology & Imaging Centre, India's premier diagnostics company, to bolster its presence in the region. The acquisition helps them keep the patient relationships and continuity post-acquisition. This is a way of further strengthening the foothold and aligning the business strategy with the specific healthcare landscape of the region. The acquisition also complements the company's directive to go deeper into developing Tier 2 and Tier 3 cities in Uttarakhand and Uttar Pradesh. The company aspires to offer more access to patients in under-represented markets to quality testing in the context of quality and trust in the not-so-distant future of diagnostics in India.
The Metropolis Company has secured DAPIC's laboratories equipped with state-of-the-art imaging and pathology technologies. Metropolis now intends to implement its very own Lab Information System and augment digital integrations across the recently acquired service centers. This would facilitate operational efficiency and increase testing capabilities, while also extending DAPIC's team access to continuing education and training at Metropolis. Metropolis is also collaborating with Ahuja leadership to ensure service continuity and proper onboarding of employees into the ecosystem of Metropolis. Existing DAPIC patients stand to gain from continuity in care alongside a wider menu of tests, digital test results, and advanced diagnostic services.
In the years ahead, the diagnostic services market in India will develop driven by an increased awareness of the healthcare system, an insurance penetration increase, and increased demand for preventive testing. Since these are organized players, such as Metropolis, there's the likelihood they'll pursue other attractive acquisitions like the DAPIC acquisition from a fragmented market. Metropolis Healthcare is getting transformed digitally and investing in artificial intelligence innovations for diagnostics essential for future growth. According to industry analysts, Metropolis is ahead in the game as the future market is evolving with its focus on quality, compliance, and technology integration. The acquisition of DAPIC, valued at Rs 35.01 crores, reveals a shift towards a more aggressive regional expansion strategy and an obvious commitment toward increasing the level of healthcare delivery in particularly high-potential markets. The fact that this partnership will be between Alok and Alka Ahuja and would be combined with Metropolis" national resources creates a promising scenario for future growth and innovation, in addition to improving patient care in northern India.
April 2025
April 2025
April 2025
April 2025